Cellestia

Our People

Cellestia is led by a Senior Management team with a proven track record in discovery and research, drug and business development, regulatory affairs, marketing and finance. Our Board of Directors has decades of experience in research, development as well as in founding, building and managing leading global life sciences companies. The management team is supported by an experienced network of advisors, all of whom have a profound and specific know-how that is relevant for the further development of Cellestia.

Management

Rajwinder Lehal

Chief Executive Officer
Board Member

More info

Gaudenz von Capeller

Chief Financial Officer

More info

Maria Bobadilla

Chief Development Officer

More info

Board of Directors

Guido Guidi

Chairman of the Board

More info

Rajwinder Lehal

Chief Executive Officer
Board Member

More info

Silvio Inderbitzin

Board Member

More info

Robert Karsunky

Board member

More info

Karen Chu

Board Member

More info

Advisors

David R. Epstein

Strategic Advisor

More info

Dr. Alfredo Covelli

Medical Director at Cellestia Biotech AG

More info

Prof. Douglas Hanahan

Director of the Swiss Institute for Experimental Cancer Research
EPFL

More info

Prof. Jon Aster

Prof. of Pathology and Chief of the Division of Hematopathology
Brigham and Women's Hospital and Harvard Medical School

More info

Prof. Rhett Kovall

Assoc. Prof. University of Cincinnati College of Medicine
Dept. of Molecular Genetics, Biochemistry and Microbiology

More info

Walter H. Koch, Ph.D.

Retired VP, Head of Global Research Roche Molecular Diagnostics

More info

Prof. Richard Herrmann

Professor of Oncology
University of Basel

More info

Dr. Renata Ferrarotto

Assoc. Prof. & Director of the Head and Neck Clinical Research Program
MD Anderson Cancer Center, Houston

More info

Dr. Marc Lang

Scientific Advisor

More info